Method for the stimulation of bone marrow cells

Patent Number: 4946437

This patent is a novel way to expand bone marrow cells ex vivo through contacting the bone marrow with a family of compounds. The single issued independent claim covers "A method for the transplantation of bone marrow cells" and the method involved contacting with a specific family of compounds. The first dependent claim states one member of this family of compounds as being trichloro(dioxoethylene-0,0')-tellurate. I believe that this patent covers the compound formally known as AS101, which was in clinical trials for a variety of indications, at least some of the trials sponsored by Wyeth.

View this patent on the USPTO website.